A 55-year-old woman on chronic hemodialysis was treated for small-cell lung cancer and associated symptoms of a paraneoplastic syndrome. Partial remission with an antineoplastic agent, an antineoplastic antibiotic, and vincristine was achieved. When the tumor advanced, carboplatin and etoposide resulted in a complete remission. Marked symptomatic improvement occurred with minimal side effects. Such examples indicate that carefully selected patients with renal failure may respond to chemotherapy and an improved quality of life.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00000441-199308000-00008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!